Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2026)

Cellebrite DI has reported Cash & Current Investments for 7 years, with the latest figure at $288.0 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 11.46% year-over-year to $288.0 million in Q2 2026; TTM through Jun 2026 was $288.0 million, a 11.46% decrease from a year earlier, with the FY2025 full-year figure at $285.5 million, down 17.34% from the prior year.
• Cash & Current Investments was $288.0 million for Q2 2026 at Cellebrite DI, up from $274.5 million in the prior quarter.
• The five-year high for Cash & Current Investments was $408.6 million in Q3 2025, with the low at $32.3 million in Q4 2023.
• Average Cash & Current Investments over 5 years is $218.4 million, with a median of $229.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 57.71% in 2022, then jumped 968.44% in 2024.
• Over 5 years, Cash & Current Investments stood at $56.6 million in 2022, then sank by 42.89% to $32.3 million in 2023, then surged by 968.44% to $345.4 million in 2024, then retreated by 17.34% to $285.5 million in 2025, then gained by 0.88% to $288.0 million in 2026.
• The last three Cash & Current Investments figures came in at $288.0 million (Q2 2026), $274.5 million (Q1 2026), and $285.5 million (Q4 2025), per Business Quant data.